AU Patent

AU2010321531B2 — Lipopeptide compositions and related methods

Assigned to Cubist Pharmaceuticals LLC · Expires 2016-11-03 · 10y expired

What this patent protects

The present disclosure provides novel powder daptomycin formulations which have improved chemical stability and faster reconstitution times when in the solid state. Some examples of the compositions comprise daptomycin and sucrose.

USPTO Abstract

The present disclosure provides novel powder daptomycin formulations which have improved chemical stability and faster reconstitution times when in the solid state. Some examples of the compositions comprise daptomycin and sucrose.

Drugs covered by this patent

Patent Metadata

Patent number
AU2010321531B2
Jurisdiction
AU
Classification
—
Expires
2016-11-03
Drug substance claim
No
Drug product claim
No
Assignee
Cubist Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.